Trump: We May Have a Deal on Gaza
Lib Reporter Drops the Most Insane Line About Latino Kids and ICE
'Hypocrisy on Steroids': Kash Patel Torches Media Over Comey Indictment
Foreigners Who Mocked Kirk’s Death Might Soon Regret It
Alvin Bragg's Office Quietly Dismissed Charges Against Woman Who Assaulted Pro-Life Activi...
Sean Duffy Announces New Emergency Rules to Overhaul CDL Eligibility
JD Vance Demands Jimmy Kimmel Apologize to Erika Kirk Following His Return to...
Georgetown Students React to Flyers Glorifying Charlie Kirk’s Assassination
Jeffries Vows Anyone Involved in Comey Indictment 'Will Face Accountability'
Inflation Data for August Is in...
Comey Posted a Video After Indictment. Here's What He Had to Say.
Trump Announces Slew of New Tariffs
Theo Von's Objection to DHS Using Him in Video Spurs Debate
Why I Cannot Forgive Charlie Kirk's Murderer
Britain's Two-Tier Policing and Enforcement Regime Is Outrageous and Undeniable
Tipsheet

'Revolving Door': What the WH Left Out of Its Announcement About Nominee for NIH Director

President Biden on Monday nominated Dr. Monica Bertagnolli, a surgical oncologist and head of the National Cancer Institute, to be the next director of the National Institutes of Health, but critics say the White House left out an important detail about her background in the administration’s announcement.  

Advertisement

“Dr. Bertagnolli has spent her career pioneering scientific discovery and pushing the boundaries of what is possible to improve cancer prevention and treatment for patients, and ensuring that patients in every community have access to quality care,” Biden said in a statement.
 
“As Director of the National Cancer Institute, Dr. Bertagnolli has advanced my Cancer Moonshot to end cancer as we know it. She has brought together partners and resources from different sectors to launch groundbreaking efforts in cancer prevention and early detection, a national navigation program for childhood cancers, and additional programs to bring clinical trials to more Americans,” the statement continued. “Dr. Bertagnolli is a world-class physician-scientist whose vision and leadership will ensure NIH continues to be an engine of innovation to improve the health of the American people.” 

As Democratic presidential candidate Robert F. Kennedy Jr. and others pointed out, she’s a “revolving door” nominee. 

“From 2015-2021, Bertagnolli received more than 116 grants from Pfizer, totaling $290.8 million. This amount made up 89% of all her. research grants,” he tweeted. 

Kennedy was sure to point out this doesn’t automatically make her “personally corrupt,” but that she will champion Big Pharma’s viewpoints.  

Advertisement

“That is how agencies are captured,” he added, commenting later that he was not surprised the White House left this detail out of the announcement. 


Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement